A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
Clinical trial NCT02429843 · COMPLETED
Trial details
- NCT number
- NCT02429843
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-02
- Primary completion
- 2018-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.